Two remaining charges against a Parkinson’s researcher recently convicted of fraud have been dropped by an Australian court.
In October, Caroline Barwood, formerly at the University of Queensland (UQ) in Brisbane, was found guilty of five out of seven charges. Subsequently, Barwood was handed two suspended sentences: one for two years, and another for 15 months, both to be served concurrently. She will not serve jail time.
Barwood was found guilty of five charges against her, but the jury could not reach a majority verdict on one count of fraud and another of attempted fraud. She was asked to re-attend court for a “mention.”
The move comes after a group of researchers alleged the paper contains missing data, and the authors followed a problematic methodology. In September, however, the co-authors’ institution, Uppsala University in Sweden, concluded there wasn’t enough evidence to launch a misconduct investigation.
PubPeer has suffered a setback in an ongoing lawsuit filed by a scientist who alleges the site’s anonymous commenters cost him a job.
This week, judges in the Court of Appeals in Michigan denied the request of the American Civil Liberties Union — which is representing PubPeer — to include an investigative report as part of evidence in the case. The report, by Wayne State University, found the plaintiff — Fazlul Sarkar — had committed widespread misconduct, and should retract scores of papers.
The University of Tokyo is investigating a 2011 stem cell paper in Cell Cycle, recently retracted over irregularities in four figures.
The university has confirmed there is an investigation, but would not specify which paper it concerned; the corresponding author on the paper, however, confirmed to us that it is the focus of the investigation.
Last year, a cancer researcher wrote to the Journal of Biological Chemistry, asking to correct one of his papers. The journal responded by requesting the raw data used to prepare his figures. Then, in a follow-up request, it asked for raw data behind the figures in 20 additional published articles.
And when all was said and done six months later, Jin Cheng ended up with far more than just a single correction: Last month, the journal issued withdrawals for 19 of his papers — including the paper he originally asked to correct — along with one correction.
We’ve pieced together some clues about what happened after reviewing correspondence between representatives of JBC and Moffitt Cancer Center, where Cheng conducted his research. A spokesperson for Moffitt confirmed that the retractions did not initiate from an institutional investigation — but that the institution is now conducting one.
That’s not the way retractions typically happen: Often, journals don’t have the resources to conduct investigations themselves, so institutions mostly take the lead in double-checking papers and, if necessary, contacting the journal to initiate a retraction. Here, it seems the opposite took place.
There are a lot of accusations about research misconduct swirling around, and not every journal handles them the same. Recently, Cell Metabolism Scientific Editor Anne Granger and Cell Metabolism Editor-in-Chief Nikla Emambokus shared some details about their investigative procedure in “Weeding out the Bad Apples.” We talked to them about why they don’t necessarily trust accusations leveled on blogs (including ours), but will consider the concerns of anyone who approaches the journal directly – even anonymously.
Three psychiatric studies of children contained a myriad of problems that may have put participants at greater risk than was disclosed by consent forms, according to a 2014 letter sent to hundreds of the participants and their families.
Through a public records request, we’ve obtained a copy of the letter — which lists a host of problems in the studies, ranging from enrolling ineligible patients, not informing families of the risks associated with the studies, and skipping tests intended to minimize the risks associated with lithium.
In 2013, Mani Pavuluri told the University of Illinois at Chicago that one of her study participants had been hospitalized — an event which prompted the university to halt three of her studies, launch a misconduct probe, and send letters to approximately 350 families of children participating in the research, notifying them of what happened.
In March, 2013, a graduate student joined the lab of a prominent researcher in Australia, investigating new therapies for Parkinson’s. A few months later, everything fell apart.
In September 2013, the University of Queensland (UQ) announced it was retracting one of the lab’s papers, returning the money used to fund the research and launching a fraud investigation. Since then, the scandal has grown to the point where the lead researcher and his co-author have been convicted of fraud in an Australian court.
Now, the graduate student is fighting back. After losing her research project and being escorted off campus for allegedly erratic behavior, she has appealed to UQ to reimburse her for tens of thousands of dollars in tuition, and is now awaiting a verdict from a government ombudsman. The graduate student goes by “Dominique,” which is not her real name; Retraction Watch is keeping her identity confidential to protect her privacy.Continue reading A grad student was caught in the crossfire of fraud — and fought back
Last week, we learned a 2016 paper heavily discussed on PubPeer might be retracted — today, we learned that Nature Cell Biology has indeed pulled the paper, citing inappropriate image modifications.
As we reported last week, a comment on PubPeer flagged as coming from an author said they had requested a retraction. A representative of National Taiwan University (NTU) told us the first author had resigned, and the paper was under investigation — an investigation which included the last author, a prominent researcher who is also a vice president at another institution in Taiwan.